INVESTOR PROFILE | Ionic Brands

Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
https://www.ionicbrands.com/
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
https://www.ionicbrands.com/
52-Week
Range
N/A
Current
Outstanding
108,436,715
Warrants
Options
Fully Diluted
Market Cap.
14,639,000
IONIC BRANDS (CSE: IONC) has a premium portfolio of cannabis concentrate consumer brands. Ionic Brands is one of the top selling concentrate company in Washington State.
Company Brief

Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands. 

They have: 

- Stylish products

- World Class Management Team

- A proven and repeatable strategy for success

Highlights

Experienced and proven luxury cannabis concentrates brand

One of the tops selling vape brands in WA State with a loyal customer base

Largest standalone oil manufacturer in the state of WA

Consistent sales growth over 3 years with a verified marketing blueprint

Offers investors exposure to a premium luxury cannabis brand

Demonstrated to have a winning formula to become the top vape company in WA

Massive growth opportunity available with expansion into OR, NV and CA

In The News
article 1 image
Ionic Is Changing the Face of Cannabis and Creating a Social Revolution
It’s all in the URL: Ionic.social. “We believe our products are best when enjoyed in a social setting,” said co-founder Christian Struzan. READ MORE
article 2 image
Marijuana Vaping Is The Most Explosive Growth Play In Marijuana Today
“Nobody smokes marijuana anymore, they vape it.” - New York Times That's not quite true. But it will be soon. READ MORE
article 3 image
How To Invest In Marijuana Vaping
The marijuana vaporization products (or just "vape") market is set to explode in 2019. READ MORE
Related Articles

Canadian Government Agency Removes Barrier for Psilocybin Therapy

2020-12-16 FinancialNewsMedia.com Staff

PALM BEACH, Fla., Dec. 16, 2020 /PRNewswire/ -- Health Canada, in a recent "breakthrough Exemption" has quietly expanded its list of who can legally possess and consume psilocybin-containing mushrooms by granting 16 health-care professionals the same exemptions it gave more than a dozen patients with terminal and mental illnesses, according to TheraPsil, a Victoria non-profit that has been behind the struggle to treat a list of mental health issues, including debilitating depression, PTSD and even terminal cancer patients. 

South Carolina Lawmakers Pre-File Medical Cannabis Reforms for 2021

2020-12-15 TG Branfalt

Lawmakers in South Carolina have pre-filed several cannabis reform measures ahead of the 2021 session: two to legalize medical cannabis, one to decriminalize possession up to one ounce, one allowing some veterans to possess cannabis, and another to hold an “advisory referendum” on broad legalization.

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

2020-12-15 Yahoo Finance Staff

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries.

UK Approves Trials Testing DMT as Depression Treatment

2020-12-14 TG Branfalt

The United Kingdom has approved trials by London-based Small Pharma for assessing the safety, and later efficacy, of N,N-dimethyltryptamine – or DMT – for depression, according to a Pharm Exec report. It is the world’s first clinical trial for studying DMT as a depression treatment.